DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...
Advances in biomedical technology are reshaping how human disease is studied and treated, providing credible alternatives to ...
However, the Asia-Pacific region is expected to witness the fastest CAGR of 9.4% from 2023 to 2032. This is attributed to expanding pharmaceutical and biotechnology sectors, the rise of contract ...
Increase in prevalence of chronic diseases, growing initiatives for minimizing pyrogen contamination, and rise in R&D activities drive the growth of the global pyrogen testing market. Rise in ...